Recent research has shown that complex carbohydrates play a critical role in a number of disease states through their role in cellular adhesion and communication. Many biotech companies are actively engaged in designing carbohydrate-based drugs for these targets.
 
Pfanstiehl can provide the building blocks for the synthesis of these complex carbohydrates. These include thioglycosides, per-benzylated and acylated mono- and disaccharides, glycals, lactones, acetonide and benzylidene derivatives.